Trial Profile
A managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Nov 2023
Price :
$35
*
At a glance
- Drugs Belinostat (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Expanded access; Therapeutic Use
- 28 Apr 2017 New trial record